Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Viking Therapeutics Today VKTX Viking Therapeutics $31.74 -1.37 (-4.14%) As of 07/31/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $97.88 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months
The doses used in animal research often far exceed those used therapeutically in humans when adjusted for body surface area
2020 Aug 26;9(9):1970
For patients also taking insulin or sulfonylureas, alcohol may increase hypoglycemia risk
25 HFA-PEFF is a diagnostic algorithm, while H2FPEF is a probability score
US$ 28.93
US$ 22.31
US$ 25.29
US$ 22.70
